TriAgenics, Inc., the pioneer of Zero3 TBA, a fully guided tooth bud ablation system designed to prevent the formation of third molars, announced that David Thrower has been named President and Chief Executive Officer.
Thrower has held a number of executive positions at the intersection of the consumer electronics and medical device markets. He was Vice President of Global Marketing for Align Technology, maker of the Invisalign orthodontic aligners. During his tenure, the company grew sales from zero in the early days to approximately $200 million.
In addition, David served as CEO of hearing aid developer InSound Medical, which was acquired by Sonova Holdings AG, and as CEO of venture capital firm Asante Solutions, where he successfully guided a novel insulin pump through FDA approval and early commercial launch.
“I am honored to join TriAgenics at a critical time as the FDA begins review of our clinical application,” said Thrower. “For decades, wisdom tooth extraction has been a painful and distressing experience – often requiring anesthesia, severe swelling, and days of missed school for patients and parents.
Preclinical animal studies show that TriAgenics’ Zero3 TBA technology has the potential to significantly reduce or even eliminate the pain and complications typically associated with this common procedure.”
Throel began his career as a strategic consultant at Bain & Company. He holds an MBA from Harvard Business School and a bachelor’s degree in mathematics and computational science from Stanford University. Thror joined the TriAgenics Board of Directors in 2020.
TriAgenics co-founder and former CEO Leigh Colby will now serve as Chief Clinical Officer.
“David brings invaluable expertise in market strategy and commercial execution. As a key architect of Align’s global aligner strategy and application plan, David played a critical role in its early commercial success,” said Colby. “David has served on the TriAgenics Board of Directors for the past five years and is very familiar with our operations and will be able to help us drive commercial launch and the next phase of growth.”
Related topics:
